Will my baby be okay? What the numbers actually say.
The short version
Outcomes for congenital heart disease span an enormous range by lesion - from defects that need no treatment at all, to complex diagnoses where surgical survival to adulthood now exceeds what most people assume. Prenatal diagnosis itself improves outcomes for serious lesions, because delivery can happen where the surgical team already is. Developmental risk is real for complex CHD and most children still fall in the normal range, with surveillance systems designed to catch and help the rest.
Why this page exists - the gap, quantified
In the paired-survey study (40 parents, cardiologists, complex CHD requiring neonatal surgery): agreement on diagnosis name GAC 0.89, need for neonatal surgery 0.81, need for further surgeries 0.66 - but on mortality risk GAC −0.04 and neurodevelopmental outcomes GAC 0.05, essentially zero. Cardiologists believed these had been conveyed. J Perinatol 2025
What are my baby's chances?
1. Will my baby survive?
Honest survival talk is range by lesion, never one number for "CHD":
- Small VSD, isolated ASD, mild valve differences often no surgery ever
- Many never need intervention; many small defects close on their own. "Most children lead healthy, normal lives" is the documented picture for isolated minor defects. Excellent outlook, most never need surgery
- TOF, TGA, coarctation surgery in infancy, typically one to two operations
- For the common major lesions repaired in infancy, survival to adulthood now generally exceeds 90% in published surgical-center cohorts - with the caveat that every lesion and center has its own numbers, which you should ask for explicitly. High survival with surgery
- HLHS and single-ventricle staged surgeries across childhood
- The most serious category. The largest long-run single-center cohort (CHOP, reported 2025 in JACC): of newborns operated on, more than 30% survived without transplant to at least age 35, a substantial share with good-to-excellent quality of life. First-year survival is lower and varies by center and anatomy - this is the diagnosis where center-specific, case-specific numbers matter most. Serious - staged care, outcomes vary
Evidence
CHOP HLHS cohort: "more than 30% survived without transplant to at least 35 years" - Journal of the American College of Cardiology, 2025 (CHOP news release, June 17, 2025, links to the study). Neurodevelopmental surveillance recommendations: AHA scientific statements on cardiac neurodevelopmental outcomes. Prenatal-diagnosis benefit on outcomes: covered in the same J Perinatol counseling literature.
2. Will my child develop normally?
This is the category where the communication gap is widest - and the one where honesty and hope coexist most clearly:
- The risk is real. Children with complex CHD (surgery in early infancy) have documented increased rates of learning differences, ADHD-type attention profiles, motor delays, and social-skill differences. This is in guidelines, not scare literature.
- Most children are in the normal range. Increased risk is not a prediction; the majority of children with complex CHD attend mainstream schools and live ordinary lives.
- There is a system for this. Cardiac neurodevelopmental follow-up programs exist at major centers precisely because the risk is known: periodic screening through school age catches difficulties early, and early support measurably helps. Guidelines recommend lifelong periodic developmental surveillance for complex CHD.
- What to ask for: whether your center has a cardiac developmental follow-up clinic, and when your baby would first be seen.
3. What will their life actually be like?
Research increasingly reports what families actually experience, not just survival: in the long-run HLHS cohort above, a significant group of adults reported good-to-excellent quality of life - "a high-performing Fontan phenotype." Studies of children and adults with repaired CHD generally report quality-of-life scores close to peers for most, with identifiable subgroups who struggle more. The honest framing: most families describe lives that are different from what they expected and still good - but the early years are hard, and support matters.
What should I ask my cardiology team?
Parents in these studies said they wished they'd asked more about the long term. Bring these:
Prognosis questions for your team
- For this specific diagnosis, what is the range of outcomes - not the average - in your center's own experience?
- What does mortality risk look like at each stage: birth, first surgery, first year, childhood?
- What are the chances of developmental differences, and what monitoring would catch them early?
- Does your center have a cardiac neurodevelopmental follow-up program?
- How many surgeries, roughly, does this diagnosis typically involve across childhood?
- What do grown-up patients with this diagnosis tell you about their lives?
- What don't we know yet, and when will we know it?
Common questions about prognosis
Is prenatal diagnosis a bad sign for prognosis?
Why do different sources give different survival numbers?
Should I read other families' stories?
What does "lifelong care" actually mean day to day?
Last reviewed 2026-08-29 · Every figure cites its study · Corrections welcome via the footer contact.